AppLovin Corporation reports Q1 2026 results on May 7 with an interesting split in its positioning data: shorts have been cutting exposure aggressively into the print, while options traders are quietly loading up on more protection than usual.
The short interest story is one of steady retreat. Short interest has fallen roughly 9% over the past 30 days to 3.9% of the free float, with most of that decline coming in a single sharp step around April 23 when shorts shed nearly 1.1 million shares in two sessions. Availability in the lending market remains extremely loose — the borrow market is barely used, with cost to borrow hovering near 0.46% and availability well above any stress level. The short score of 37.8, sitting comfortably below the midpoint of the 0–100 scale, confirms the picture: this is not a heavily contested stock in the lending market. The ORTEX short score ranks at the 44th percentile versus the broader universe, solidly average.
Options positioning tells a more defensive story, and it deserves its own read. The put/call ratio has climbed to 0.81, more than two standard deviations above its 20-day average of 0.76 — the most stretched defensive reading of the past year short of the 0.92 recorded at the 52-week peak. That's not extreme panic, but it is a measurable uptick in demand for downside protection that arrived precisely as the stock ran 6.5% on the week and 24% over the past month to $478. When a stock rallies hard into earnings, a rising PCR z-score says options traders are paying up to hedge rather than extending into calls — the setup looks cautious rather than greedy.
The Street remains broadly constructive but is trimming ambitions. UBS maintained its Buy rating on May 5, the day before the print, but cut the price target from $740 to $716 — still 50% above the current price. Several firms did the same after February's last earnings release: Citigroup, Jefferies, and others all kept Buy-equivalent ratings while scaling back targets from the $800s into the $700s. The mean target across the coverage universe is now $638.50, reflecting a Street that still sees material upside but has absorbed some valuation reset. Goldman remains the notable holdout at Neutral, with a $585 target that is actually below where the stock closed this week. The EPS momentum factor scores rank in the 89th–91st percentile versus peers, reflecting a consensus that estimates have been rising strongly — a backdrop that traditionally sets a high bar for any beat to matter.
The bull case centers on Axon-driven e-commerce monetization. Analysts pointing to the 4.4% increase in brand activity using the Axon Pixel, and 9% projected e-commerce revenue growth for FY26, frame AppLovin as a platform scaling beyond its gaming base. The bear case is essentially a valuation-and-opacity argument: the stock trades at a P/E near 27x and a P/B above 23x, both up meaningfully over the past 30 days as the stock re-rated higher, and critics question whether the AXON 2 optimizer's edge is as durable as bulls imply given the nascent and still-unguided e-commerce segment.
The February earnings reaction casts a long shadow ahead of this print. The last two reported quarters each produced sharp declines — the stock fell 22% on the day of the February 2026 results and a further 14% over the five-day window, even as annual estimates moved higher afterward. That history is almost certainly part of why options traders are reaching for protection now after a 24% one-month run into the number. Close peer PLTR dropped 6.9% on Wednesday alone while ORCL added 2.8% on the week — a mixed tech backdrop that underlines how stock-specific this print will be.
What to watch: whether Q1 revenue and EBITDA margins confirm the e-commerce ramp that analysts have baked into raised FY26 estimates — and whether management offers any clearer financial framework for the business beyond gaming, the single variable that has so far divided the bull and bear camps most sharply.
See the live data behind this article on ORTEX.
Open APP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
